A major breakthrough in cancer study is arising with the use of VHH fragments to reactivate dysfunctional p53. This essential tumor inhibitor protein is frequently disabled in several types of cancer, causing https://bookmarkspiral.com/story21945322/mini-antibodies-reactivate-p53-the-promising-pathway-for-malignant-treatment